7 days in healthcare (September 12th-18th, 2022)

/in /by

 

Summary

From the point of view of biomedicine, immunotherapy (in colon cancer) and CAR-T therapies (in lupus) continue to expand their therapeutic possibilities. Advances against infections for resistant bacteria. Will there ever come a time when cancer can be diagnosed by a simple blood test? This possibility does not seem very remote, according to papers presented at the meeting of the European Society of Medical Oncology.

Regarding Global Health, an important work directed by Jeffrey Sachs and published by The Lancet on the delays and errors of both governments and the WHO in dealing with the covid pandemic, which could have produced 17.7 million of  deaths, many of them preventable.

Regarding international health policy, the WHO says that the end of the covid pandemic may be in sight, although at the same time a new variant (BJ.1) of covid is evident in Europe. Important debate in Europe (Scotland and France) on euthanasia and assisted death. The French Ethics Committee opens the door to this possibility. The financing of the American FDA was questioned, due to its great economic dependence on the pharmaceutical industry. Biden launches a speech commemorating Kennedy’s in 1962 when he decided to go to the Moon, but this time oriented towards the fight against cancer.

If we talk about national health policy (Spain), the PDeCAT presents an amendment to the entire equity law, which it accuses of interfering in regional powers and of confusing agreement with privatization. Surprising statements from the Ministry of Health in a parliamentary response, saying that its functions in relation to the waiting lists are only to inform and monitor, as if it did not have the possibility of signing agreements with the communities to address this problem or of launching other actions. Concern, there are even demonstrations in the street, of the relatives of the elderly admitted to residences. The Community of Madrid announces that it will reduce the waiting lists by half. Although we would like it not to be the case this time, this announcement is preceded by other similar ones from different governments, which always came to nothing in terms of effectiveness. The search for solutions by the Ministry of Finance to the MUFACE model, highly impacted by inflation, seems to recognize its underfinancing.

In the field of companies, from the international point of view, important success for Sanofi, with its new vaccine against bronchiolitis. In Spain, important corporate movements in Korian, HM Hospitales, Miranza and Ribera.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

7 days in healthcare (September 5th-11th, 2022)

/in /by

 

Summary

From the point of view of Biomedicine, to highlight the work that shows an association between artificial sweeteners and increased cardiovascular risk. Also that air pollution causes lung cancer.

As far as Global Health is concerned, apart from the serious humanitarian crises in Pakistan and Somalia, the most promising is the new malaria vaccine, which could be operational as early as 2023.

Regarding international health policy, assisted suicide and euthanasia are news in Canada (where the rate of euthanasia is very high and there is concern) and in France (which is considering passing a law). Macron has launched a major national debate on this issue, following a report to appear next week from the Ethics Committee. This great debate on such a delicate subject was missed in Spain. Certain issues should not be subject only to conjunctural parliamentary majorities, but should be preceded by a great national debate. It is also worth mentioning that Chile rejected the draft Constitution in a referendum. According to an article published in El País, doubts about the possibility of choosing the health system (the continuity of the ISAPRES, as health insurers are called in Chile), is one of the causes of this rejection.

If we talk about national health policy (Spain), it should be noted that Aragón proposes a great debate on the efficiency of the National Health System, a brave and valuable initiative. It will first analyze the Aragonese health system, and then share that analysis with the rest of the autonomies. Also that the Ministry of Health promises to change the law to favor the local manufacture of medicines. It is also worth underlining the pronouncement of the Catalan Evaluation Agency, on the need for a state policy for the digital transformation of the health system and the promotion of telemedicine.

In the field of companies, from the international point of view, to mention the purchase of Signify a home care group by CVS (an American pharmaceutical chain), in a process in which Amazon also showed interest. In terms of news at the national level, to highlight the great investment of Novartis in our country.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

7 days in healthcare (August 29th-September 4th, 2022)

/in /by

 

Summary

From the point of view of Biomedicine, the great impact of the study by scientists from the University of Oviedo, who have studied the genes of a species of jellyfish, which incorporates rejuvenation elements in its life cycle, should be highlighted.

With regard to Global Health, historical decline in life expectancy in the United States, which went to 76 years in 2021, compared to 79 in 2019. The covid, the main responsible, although not the only one. Presumably we will see a similar phenomenon in Europe and in Spain.

Regarding International health policy, both the FDA and the EMA approve the covid vaccine boosters, despite some questions that have been pointed out by the journal Science. In the UK, long waiting lists in the public sector are leading to a boom in direct payment systems for healthcare.

If we talk about national health policy (Spain), the two most relevant issues are the approval of the bill that creates the Spanish Public Health Agency, subject to hearing and public information; and the draft Law on Abortion, which has very controversial elements, such as abortion in women aged 16-18 without information or parental consent; conscientious objection for doctors (on whose regulation the WTO has ruled negatively); the obligation to carry out this practice in public centers; and the dispensing of the morning after pill. Surprising statements by the President of the Community of Madrid, who attributes the shortage of doctors to the lack of Faculties of Medicine, contrary to what had been the opinion of the State Confederation of Medical Students and the Conference of Deans of Faculties of Medicine, with the support of the Forum of the Medical Profession. And the fact that only South Korea surpasses Spain in the ratio of Faculties of Medicine per million inhabitants.

In the field of companies, health has jumped into the metaverse with a business of 5,060 million dollars, although we will have to be very attentive to what we call metatarsus. HIPRA starts a trial to study its covid vaccine as a fourth dose.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

 

 

7 days in healthcare (August 21st-28th, 2022)

/in /by

 

Summary

From the point of view of biomedicine, the very encouraging results of the polypill published by a Spanish group led by Valentin Fuster should be highlighted. The Economist underlines the great future of gene therapies in medicine, with a list of diseases for which there is a therapy or is in advanced study.

Regarding Global Health, The Lancet publishes a report with some conclusions and lessons regarding future pandemics.

As for International Health Policy, both monkeypox and covid are plummeting in Europe. The controversial annulment of the Roe v Wade ruling in the United States, which leaves the right to abortion to the criteria and regulation of the states, continues to be talked about. American companies, including Walmart, the largest American employer, introduce this benefit for women, regardless of the state where they work.

If we talk about National Health Policy (Spain), covid continues to drop and especially the number of cases in the ICU. The Government approves the bill that creates the Public Health Agency, probably the largest, if not the only, far-reaching measure after the pandemic. The text of the law is not yet public, and therefore important aspects such as governance and functions are not known. The location is not known either, although the Government has advanced that it would not be in Madrid, which is not without controversy either. Next week the government will approve the abortion law, according to a text promoted by Podemos.

In the field of companies, Moderna’s lawsuit against Pfizer and BioNTech has been shocked, which it accuses of plagiarism of its mRNA technology in the covid vaccine. Amazon closes its telecare service, which once again demonstrates the difficulties of the large technology platforms in finding an adequate strategy for health, a sector in which they want to be above all else. In Spain, the export of drugs manufactured in Spain grows by 60% in one year.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

 

 

 

7 days in healthcare (August 15-21, 2022)

/in /by

Summary

From the point of view of biomedicine, the first drug is prepared using CRISPR (gene editing) technology. Important publication from The Lancet in the largest effort yet to identify risk factors in relation to cancer. Not surprisingly, however, tobacco and alcohol are the biggest risk factors, particularly tobacco.

As far as Global Health is concerned, polio is back and the UK is now offering vaccinations to children in London between the ages of 1 and 9.

Regarding international health policy, the famous North American Inflation Reduction Act has been signed by President Biden. Despite its name, the law has more to do with climate change and health, especially drug prices. No large growth in monkeypox is predicted, based on modeling carried out by The Economist. Deaths from covid remain high (15,000 a week globally) warns the Director General of the WHO. The Director of the American CDC denounces serious failures in the management of covid and announces substantial changes in the functioning of this body. A clear contrast to what is happening in Spain, where no conclusions seem to be drawn from the management of covid, despite being one of the most affected countries in terms of the number of cases and mortality in relation to the population.

If we talk about national health policy (Spain), the good news are that covid continues to decline, although there are still 62 deaths per day. The approval of the State Center for Public Health, scheduled for next week, is possibly the biggest consequence of covid. The birth rate in Spain falls to historical lows.

In the field of companies, drug prices break historical records in the USA. In Spain, HIPRA is preparing to manufacture 250 million doses of covid vaccines, pending approval by the EMA.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

7 days in healthcare (August 8th-14th, 2022)

/in /by

 

Summary

From the point of view of biomedicine, there seems to be a glimpse of a new drug to prevent the transmission of HIV/AIDS, for which there are problems in obtaining an affordable price. Animal testing is the basis for certain advances in medicine. This can be overcome with certain new discoveries, according to the company Lift Sciences.

Regarding Global Health, two key issues: a new zoonosis (“Langya”) appears in China, as published in the NEJM. In certain developed countries it seems that polio, which was considered eradicated, is making a comeback.

Regarding international health policy, the approval of the Inflation Reduction Act (IRA) of 2022 in the United States, about Climate, Fiscal and Health will have a very important impact. Aside from expanding access to insurance through the Affordable Care Act (Obamacare), surely the most far-reaching impact will be on the pharmaceutical industry. Gradually, Medicare will be able to negotiate the price of medicines with the pharmaceutical industry, something that until now it could not do. This radically changes the business model of the pharmaceutical industry, which was based on two things: the protection of intellectual property through patents; and the existence of free prices with high margins in the United States (the largest pharmaceutical market) and regulated prices and lower margins in the rest of the world. A substantial change that will most likely have a global impact. It may also curb the escalation of health care spending in the United States. We’ll see if this doesn’t upset the fast pace of drug innovation.

If we talk about national health policy (Spain), the good news is that, as in all of Europe, covid continues to decrease in incidence, although it is still a worrying disease, due to the number of hospitalized cases and mortality.

In the field of companies, trials for new covid variants begin by BioNTech and Pfizer. More than 2,300 Spanish pharmacies can now sell through the Glovo platform and soon Uber, although only parapharmacy products, not prescription drugs.

Biomedicine

Global health

International health policy

National health policy

Companies

 

 

 

 

 

7 days in healthcare (1st-7th August 2022)

/in /by

 

 

Summary

From the point of view of biomedicine, to highlight the use of monoclonal antibodies to combat malaria; also the return to life of cells and tissues in dead pigs, which may be important in transplants; and, the fact that the genomic map of chronic lymphatic leukemia has been completed, which, sooner or later, will have consequences in the treatment of this disease.

As far as Global Health is concerned, the poor preparation of most countries in the face of the increasingly frequent heat waves is confirmed, according to The Lancet.

As for international health policy, the United States declares monkeypox a public health emergency, the Administration covering itself up against certain accusations of slowness in dealing with this problem; global decline in the number of covid cases, particularly in Europe. Problems continue in the United States due to restrictions on abortion. Three news to highlight in the United States: the number of uninsured reaches the record low figure of 8%; the American Democrats have a majority in Congress within reach to approve the law that tries to reduce the price of medicines, by way of allowing Medicare to negotiate prices; and, finally, for the first time in decades, health spending in the United States fell in the first quarter of 2022, although it is doubtful that this will continue.

If we talk about national health policy (Spain), monkeypox continues with a very high number of infected people and a shortage of vaccines; large drop in the incidence of covid. Great and difficult to justify delay in the report commissioned by the Ministry of Health from experts on the management of the covid pandemic. Surely there will be more than technical analysis problems in the cause of this delay. The doctors of the private health, threaten with the copayment, before what they consider low rates of the insurers.

In the field of companies, Pfizer continues with its aggressive policy of buying companies, while the growth of Quirónsalud, which already exceeds 2 billion euros in turnover, should be highlighted.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

 

7 days in healthcare (25th-31st July, 2022)

/in /by

 

Summary

From the point of view of biomedicine, it should be noted that the origin of acute childhood hepatitis has been discovered, it turns out to be due to a co-infection of two viruses, ruling out covid as the cause of this disease. Major advances by a group of Yale scientists in the treatment of brain tumors, specifically aggressive glioblastoma multiforme, using molecules that attack tumor DNA. Deep Mind (a company of the Alphabet group, parent of Google) launches an algorithm capable of identifying the structure of proteins. It seems that this advance may be of great importance for the discovery of new drugs.

As far as Global Health is concerned, air pollution is a public health emergency, according to the British Medical Journal. The WHO reaches an agreement on a treaty on pandemics, which should be agreed in May-2024.

Regarding international health policy, mention should be made of the declaration by the WHO of monkeypox as a global public health emergency, which is justified by the existence of more than 17,300 cases in more than 70 countries. It seems that it is confirmed that covid-19 originated in the live animal market in Wuhan (China).

If we talk about national health policy (Spain), two deaths in Spain as a result of monkeypox (in both cases due to encephalitis). At the present time there is only one other case of death from this disease in Brazil. The incidence of covid-19 drops very significantly, moving us away from the peak of the seventh wave.

In the field of companies, it should be noted that Fujijilm is going to be transformed into a health company. Teladoc’s notable financial losses. Vivalto Santé, an important French group, acquires the property of Ribera through the sale of Centene Corporation.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

7 days in healthcare (June 27th-July 3rd, 2022)

/in /by

Summary

From the point of view of biomedicine, surprising finding that the flu vaccine helps prevent Alzheimer’s.

As far as Global Health is concerned, the ravages of the war in Ukraine are noted. Most of the morbidity and mortality is not caused by direct military action, but by problems of assistance and malnutrition. Interesting article in The Lancet about the need to put an end to a global problem: the marriage of girls under 18 years of age, which is also the cause of many health problems.

Regarding international health policy, it should be noted that the WHO is concerned about the possible spread of monkeypox among children and pregnant women. Regarding covid, a study among the G10 countries (Spain is not included) demonstrates the outstanding performance of Canada in its fight against covid, second only to Japan. Almost unanimity among the scientific and opinion press on the negative consequences of the annulment of the Roe v Wade ruling, leaving the legalization of abortion in the hands of the American States. It is insisted that previous experience shows that the ban does not change the number of abortions, but rather their safety. Condemns also from the American Medical Association (the American medical colleges) and the Association of American Medical Colleges (which represents the academic medical world in the USA). More online health care is expected as a result of the digitalisation plan of the British NHS.

If we talk about national health policy (Spain), given the increase in the incidence of covid and the increase in cases of hospitalization and deaths, Minister Darias recommends the use of masks indoors. Doubts about the credibility of this recommendation, after months minimizing the impact of covid and talking about “flu”. It was approved the so-called “Trans law”, which has consequences on the SNS. Significant opposition in Catalonia (both from the government and from associative entities, such as the UCH) to the Equity Law project approved by the government.

In the field of companies, regardless of their utility or not, great growth in the activity of vendors of “traditional medicine”, which in China have the support of the government. Spanish health technology companies request a plan, given the supply crisis and the increase in costs.

Biomedicine

Global health

International health policy

National health policy

Companies

 

 

 

7 days in healthcare (June 13th-20th, 2022)

/in /by

 

Summary

From the point of view of biomedicine, to highlight the new therapy against a disease as terrible as ALS tested in Canada. Unfortunately there are doubts as to its effectiveness.

As far as Global Health is concerned, it is verified that it is the vaccine nationalism of the States that has led to the failure of COVAX, which failed to extend covid vaccination to poor countries in significant percentages.

Regarding international health policy, the approval in the United States of the covid vaccination for children under five years of age should be highlighted. Also the agreement of the World Trade Organization regarding the temporary suspension of patents on covid vaccines, something he was discussing for two years. We will see if this agreement translates into relevant measures. For now, the IFPMA (World Association of Pharmaceutical Manufacturers) has already spoken out against it. Hospitalizations for covid increase in Europe, specifically in France, Germany and the United Kingdom.

If we talk about national health policy (Spain), we must mention the controversial announcement by the Minister of Health of the fourth dose of covid for the entire population, something partially rectified by the Ministry itself and which has been rejected by many experts. Also the approval by the Government of the preliminary draft of the Equity Law. Great controversy with the private sector, since it tries to minimize and declare exceptional the collaboration of the private sector in the public service of the National Health System. But by declaring “direct management” as preferable in the SNS, it also positions itself against the more entrepreneurial development of public management, despite the fact that the benefits of legal personality and the labor regime are known in terms of greater efficiency than direct management. On the other hand, the draft may undermine the powers of the autonomous communities, since health management (and therefore the way of carrying it out) is a transferred matter. It is not surprising that very important Catalan institutions (such as UCH, CSC, ACES and Círculo de Sanidad) have taken a position against it. Important demonstration by nurses in the center of Madrid, highlighting the importance of the abandoned professional policy in the National System of Health.

In the field of companies, it is worth noting the birth of the largest pediatric oncology center in Spain and one of the largest in Europe: the one located in the Sant Joan de Deu Hospital in Barcelona. Expansión highlights that the remarkable growth of health insurance is compatible with a loss of its operating profitability.

Biomedicine

Global health

International health policy

National health policy

• Monkeypox

• COVID

• Regulatory announcements

• Other themes

Companies